🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07303543
Recruiting Not applicable

Preventing Muscle Loss After Bariatric Surgery: Protein-Collagen Supplementation and Resistance Exercise

NCT07303543 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2022-08-02
Last updated
2025-12-26

Condition(s) studied

Bariatric SurgeryMuscle Loss

Investigational drug(s) / intervention(s)

Whey protein supplementHydrolyzed Collagen SupplementVitamin and Mineral SupplementationResistance Exercise Program

Whey protein supplement: Oral whey protein supplement provided daily according to bariatric surgery nutrition protocol.

Hydrolyzed Collagen Supplement: Oral hydrolyzed collagen supplement provided daily in combination with whey protein.

Vitamin and Mineral Supplementation: Routine vitamin and mineral supplementation according to bariatric surgery follow-up protocol.

Resistance Exercise Program: Structured resistance exercise program initiated at postoperative week 4, supervised, 3 times per week.

Study summary

The aim of this clinical trial is to investigate the effectiveness of collagen, considered a new approach to prevent muscle mass loss after bariatric surgery, and to demonstrate the relationship between this effect and exercise. The key questions it aims to answer are:

Does whey protein supplementation with collagen combined with resistance exercise prevent muscle mass loss after bariatric surgery? Do whey protein supplementation with collagen combined with resistance exercise affect fat mass after bariatric surgery?

Researchers will compare collagen with whey protein.

The study groups and interventions to be implemented are summarized below:

Group 1: Control Group (CG; n: 10) Whey protein supplementation will be administered Vitamin and mineral supplementation will be administered No resistance exercise will be performed The participants will eat according to bariatric surgery nutrition guidelines and perform physical activities.

Group 2: Whey Protein + Collagen + Exercise Group (WPCEG; n: 10) Whey protein supplements with collagen will be given. Vitamin and mineral supplements will be given. Resistance exercise will be performed. They will eat according to bariatric surgery nutrition guidelines and perform physical activities.

They will begin a resistance exercise program 4 weeks after surgery.

Group 3: Whey Protein + Collagen + No Exercise Group (WPCG; n: 10) Whey protein supplements with collagen will be given. Vitamin and mineral supplements will be given. No resistance exercise will be performed. They will eat according to bariatric surgery nutrition guidelines and perform physical activities.

Group 4: Whey Protein + Exercise Group (WPEG; n: 10) Whey protein supplements will be given. Vitamin and mineral supplements will be given. Resistance exercise will be performed. They will eat according to bariatric surgery nutrition guidelines and perform physical activities.

A resistance exercise program will begin at 4 weeks post-operatively.

Eligibility

Sex
ALL
Min age
20 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Being between 20-50 years old * Body mass index; 35 ≤ BMI\< 60 kg/m2 * Not being pregnant * Not being addicted to alcohol and drugs * Not having entered menopause * No exercise restrictions Exclusion Criteria: * Having at least one of the following inflammatory bowel diseases, upper gastrointestinal bleeding, advanced psychiatric diseases, cancer, and kidney failure. * using statins * be pregnant * Being addicted to alcohol and drugs * to have entered menopause * Having exercise restrictions * Becoming a professional athlete * Having done more than 60 minutes of regular and structured exercise per week in the last year

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul Medipol University Istanbul Fatih Recruiting

More Medipol University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07303543 on ClinicalTrials.gov ↗ ← All trials in Turkey